Table 2.
Descriptive statistics for clinical outcome measures
| Outcome measure | Baseline | End of robot-assisted intervention | End of conventional intervention | |||
|---|---|---|---|---|---|---|
| Group A | Group B | Group A | Group B | Group A | Group B | |
| FMA-UE | 33 (8.53) | 36.4 (10.1) | 35.64 (9.3) | 34.7 (11.02) | 36.43 (9.53) | 38.8 (10.32) |
| WMFT-Time | 14.85 (6.19) | 12.09 (6.5) | 12.52 (5.92) | 9.07 (4.51) | 12.41 (6.21) | 11.05 (6.03) |
| WMFT-FAS | 2.51 (.44) | 2.65 (.71) | 2.63 (.58) | 2.83 (.77) | 2.75 (.7) | 3.31 (.99) |
| MAL-AOU | 1.15 (.82) | .97 (1.13) | 1.33(.82) | 1.09 (1.15) | 1.58 (1.04) | 1.25 (1.27) |
| MAL-QOM | .76 (.48) | .78 (.95) | .86(.56) | 1.12 (1.07) | 1.08 (.76) | .89 (.94) |
| ARAT | 14.5 (9.24) | 18.8 (12.13) | 16(9.03) | 22.4 (10.34) | 20.07 (13.98) | 21.9 (15.2) |
Data are presented as the mean (SD)
FMA_UE upper limb subtest of the Fugl-Meyer assessment, WMFT-Time performance time of the Wolf Motor Function Test, WMFT-FAS functional ability scale of the Wolf Motor Function Test, MAL-AOU Motor Activity Log Amount of use score, MAL-QOM Motor Activity Log Quality of movement score, ARAT Action Research Arm Test